As regulatory professionals tasked with protecting research subjects, it’s important to understand the unique risks and benefits of social media use for research

Quick Read

Everyone would benefit if researchers did more to make participants feel part of a study

Quick Read

There’s very little research on whether medications are safe and effective in pregnant and lactating women, but an expert panel has ideas for how to close that information gap — and it’s calling on the federal government to take action in a new report that could stir change

Quick Read

A trial enrolling new patients resembles “an experiment that would be conducted on laboratory animals,” one advocacy group said

Quick Read

There are now several experimental treatments vying to be tested, but each must be greenlit by national regulatory authorities whenever and wherever an outbreak occurs. There remain deeply divergent positions among scientists about how to design outbreak trials, specifically whether studies that don’t compare treatments to placebos can generate useful data

Quick Read

Drugs that activate the immune system to fight cancer have brought remarkable recoveries to many people in recent years. But one of those drugs seems to have had the opposite effect on three patients with an uncommon blood cancer who were taking part in a study

Quick Read

Leading scientists propose to track salt’s effects on health by controlling how much is given to inmate volunteers

Quick Read

Basic researchers who study the brain and human behavior thought lawmakers had come to their rescue in March by blocking the National Institutes of Health (NIH) in Bethesda, Maryland, from redefining their studies as clinical trials. But NIH officials are still pushing ahead with new requirements that scientists say make no sense and will cripple their research

Quick Read